Career advice from pharma professionals
In an industry which has excelled in the face of adversity this year, some expert advice can help you do the same in your...
Changes to the landscape of commercial recruitment
As Covid-19 continues to shift and shape the landscape of commercial recruitment, Pf talks with Andy Anderson at Evolve about its impact going forward. How...
Why candidates need to be omnichannel ready
Judy Phillips from Chase looks at how working practices are changing and why it is important that candidates in 2020 are omnichannel ready. COVID-19 and...
Interview with Pf Awards Future Leader winner
In this interview, Pf Awards Future Leader winner, Lauren Laskier, reflects on her accolade and how the recognition has pushed her forward in her...
Surviving redundancy
Clare Hill, Owner of Smart Culture Psychology, looks at how, as furlough comes to an end and companies review their workforces, redundancies are inevitable....
Interview with Pf Awards Primary Care Specialist winner
Pf Awards winner Nick Meeks on how winning the Award has catapulted his career and how COVID-19 changed his course, causing him to reflect...
Has Covid-19 changed working practices in the UK for good?
Emma Clayton, Managing Director of Grey Bear Consultancy, looks at how the pandemic has changed working practices – what are the benefits and challenges...
COVID-19: changing the pharma workforce
There’s no denying the COVID-19 has changed the world, but will it have a lasting effect on the pharma workforce? Graham Hawthorn
Managing Director, CHASE It is...
Job seeking during COVID-19
Pf asked industry leading recruiters for their top tips for job seeking during COVID-19. Tips for virtual interviewing Consider what you wear – look professional.
...
Logical reasoning tests: What you need to know
Logical reasoning tests are a cornerstone of aptitude tests. They comprise the foundation for many job interviews on assessment days. But what can you...
Latest articles
NICE recommends Tagrisso for patients with early-stage lung cancer
Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
JCVI responds to Omicron variant and updates its guidance
The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
EC grants marketing authorisation for breast cancer treatment Trodelvy
The European Commission (EC) has granted marketing authorization for Gilead Sciences’ Trodelvy® (sacituzumab govitecan), as a monotherapy indicated for the treatment of adult patients with...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT
What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
JCVI responds to Omicron variant and updates its guidance
The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
NICE recommends Tagrisso for patients with early-stage lung cancer
Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
Sales excellence within a value-based promotional model
Forward thinking brand teams are developing a value-based promotional model to promote products in a way which is perceived as offering real differentiation In 2006,...